EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial

Scott Evans

PLoS Clinical Trials · 13.04.2007 · 2 (4) · e18

DOI: 10.1371/journal.pctr.0020018 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLoS Clinical Trials, online erschienen am 13.04.2007. Verfasst von Scott Evans. Beteiligte Einrichtung: Center for Biostatistics in AIDS Research, Department of Biostatistics, Harvard School of Public Health, Harvard University, Boston, Massachusetts, U…. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

It is unclear whether insulin-like growth factor (IGF) function is involved in the pathophysiology of chronic fatigue syndrome (CFS).Unpublished data and reports in patient organization newsletters suggest that Acclydine, a food supplement, could be effective in the treatment of CFS by increasing biologically active IGF1 levels.Here we aimed to measure the IGF1 and IGF binding protein (IGFBP) 3 status of CFS patients compared to age-and gendermatched neighborhood controls, and to assess the effect of Acclydine on fatigue severity, functional impairment, and biologically active IGF1 level (IGFBP3/IGF1 ratio).

Design

A randomized, placebo-controlled, double-blind clinical trial.

Autor:innen und Institutionen

  • Center for Biostatistics in AIDS Research, Department of Biostatistics, Harvard School of Public Health, Harvard University, Boston, Massachusetts, United States of America. evans@sdac.harvard.edu

Zitieren

APA

Evans, S. (2007). When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial. PLoS Clinical Trials, 2(4), e18. https://doi.org/10.1371/journal.pctr.0020018

Vancouver

Evans S. When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial. PLoS Clinical Trials. 2007;2(4):e18. doi:10.1371/journal.pctr.0020018

BibTeX
@article{Evans2007,
  author = {Evans, Scott},
  title = {When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial},
  journal = {PLoS Clinical Trials},
  year = {2007},
  volume = {2},
  number = {4},
  pages = {e18},
  doi = {10.1371/journal.pctr.0020018}
}
Kostenlos starten →